Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review.
- Author:
Chan Bum CHOI
1
;
Yong Beom PARK
;
Sang Won LEE
Author Information
- Publication Type:Review
- Keywords: Antineutrophil cytoplasmic antibody; vasculitis; Korea
- MeSH: Antibodies, Antineutrophil Cytoplasmic; Classification; Consensus; Cytoplasm*; Eosinophils; Granulomatosis with Polyangiitis; Humans; Incidence; Korea*; Microscopic Polyangiitis; Mortality; Rheumatology; Survival Rate; Vasculitis*
- From:Yonsei Medical Journal 2019;60(1):10-21
- CountryRepublic of Korea
- Language:English
- Abstract: Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is a group of systemic necrotising vasculitides, which often involve small vessels, and which lead to few or no immune deposits in affected organs. According to clinical manifestations and pathological features, AAV is classified into three variants: microscopic polyangiitis, granulomatosis with polyangiitis (GPA), and eosinophilic GPA. The American College of Rheumatology 1990 criteria contributed to the classification of AAV, although currently the algorithm suggested by the European Medicines Agency in 2007 and the Chapel Hill Consensus Conference Nomenclature of Vasculitides proposed in 2012 have encouraged physicians to classify AAV patients properly. So far, there have been noticeable advancements in studies on the pathophysiology of AAV and the classification criteria for AAV in Western countries. However, studies analysing clinical features of Korean patients with AAV have only been conducted and reported since 2000. One year-, 5 year-, and 10 year-cumulative patient survival rates are reported as 96.1, 94.8, and 92.8%. Furthermore, initial vasculitis activity, prognostic factor score, age and specific organ-involvement have been found to be associated with either all-cause mortality or poor disease course. The rate of serious infection is 28.6%, and 1 year-, 5 year- and 10 year-cumulative hospitalised infection free survival rates range from 85.1% to 72.7%. The overall standardised incidence ratio of cancer in AAV patients was deemed 1.43 compared to the general Korean population.
